amantadine has been researched along with Pantothenate Kinase-Associated Neurodegeneration in 2 studies
amant: an antiviral compound consisting of an adamantane derivative chemically linked to a water-solube polyanioic matrix; structure in first source
Pantothenate Kinase-Associated Neurodegeneration: A rare autosomal recessive degenerative disorder which usually presents in late childhood or adolescence. Clinical manifestations include progressive MUSCLE SPASTICITY; hyperreflexia; MUSCLE RIGIDITY; DYSTONIA; DYSARTHRIA; and intellectual deterioration which progresses to severe dementia over several years. (From Adams et al., Principles of Neurology, 6th ed, p972; Davis & Robertson, Textbook of Neuropathology, 2nd ed, pp972-929)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Al-Shorafat, DM | 1 |
| Lang, AE | 1 |
| Dooling, EC | 1 |
| Schoene, WC | 1 |
| Richardson, EP | 1 |
2 other studies available for amantadine and Pantothenate Kinase-Associated Neurodegeneration
| Article | Year |
|---|---|
Amantadine for Gait Dysfunction in Pantothenate Kinase-Associated Neurodegeneration.
Topics: Adolescent; Amantadine; Dopamine Agents; Female; Gait; Gait Disorders, Neurologic; Humans; Male; Pan | 2019 |
Hallervorden-Spatz syndrome.
Topics: Adult; Amantadine; Autopsy; Brain; Brain Diseases; Cerebral Cortex; Deferoxamine; Electroencephalogr | 1974 |